Core Viewpoint - The company reported a decrease in revenue and profit for the six months ending June 30, 2025, primarily due to a decline in outpatient and inpatient visits, as well as pricing adjustments in response to market competition and national policies [1] Financial Performance - The company achieved revenue of 698 million, a year-on-year decrease of 4.91% [1] - Profit attributable to the parent company was 114 million, reflecting a year-on-year decrease of 16.72% [1] - Basic earnings per share were 0.16 [1] Operational Challenges - The decline in revenue was attributed to a slight decrease in outpatient and inpatient visit numbers, which are primarily focused on basic ophthalmic services [1] - The company plans to implement internal pricing adjustments starting in the second half of 2024 to address increasing market competition and the impact of the national volume-based procurement (VBP) policy [1]

Core Viewpoint - The company, Chaoyue Eye Care (02219.HK), reported a decline in revenue and profit for the six months ending June 30, 2025, primarily due to decreased patient visits and pricing adjustments in response to market competition and national policies [1] Financial Performance - Revenue decreased by 4.9% to RMB 698 million [1] - Net profit fell by 17.1% to RMB 110 million [1] - Profit margin declined from 18.2% in the same period of 2024 to 15.9% for the six months ending June 30, 2025 [1] - Basic earnings per share decreased by 17.2% from RMB 0.20 in 2024 to RMB 0.16 [1] Operational Challenges - The decline in revenue was attributed to a slight decrease in outpatient and inpatient visits primarily focused on basic ophthalmic services [1] - The company implemented internal pricing adjustments starting in the second half of 2024 to cope with increasing market competition and the national volume-based procurement (VBP) policy [1]